Skip to main content
. Author manuscript; available in PMC: 2011 Dec 29.
Published in final edited form as: Hepatology. 2010 Sep;52(3):1046–1059. doi: 10.1002/hep.23779

Figure 4. Comparison of the expression profile of survival and mitogenic factors between CCl4-treated CB2−/− mice and WT counterparts.

Figure 4

(A) RT-PCR analysis of iNOS TNF-α and IL-6 mRNA (B) MCP-1, IL-10, TLR4 mRNA following CCl4 administration. *P<0.05 for CB2−/− vs WT mice; # P<0.05 for CCl4 vs MO.